Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

EMA's CHMP recommends approval of Suliqua

Nov. 14, 2016

Harvard College reports insulin-degrading enzyme inhibitors

Nov. 14, 2016

Ultragenyx Pharmaceutical withdraws conditional MAA from the EMA for Ace-ER

Nov. 14, 2016

EMA adopts positive opinion for Novo Nordisk's Fiasp

Nov. 14, 2016

European approval for Parsabiv to treat secondary hyperparathyroidism in hemodialysis patients

Nov. 14, 2016

Glucagon/thyroid hormone conjugate improves experimental metabolic conditions

Nov. 11, 2016

PhaseRx reports positive results from animal study of PRX-OTC

Nov. 9, 2016

Eloxx Pharmaceuticals reports orphan drug designations for ELX-02 from both FDA and EMA

Nov. 9, 2016

The Medicines Company discontinues development of MDCO-216

Nov. 8, 2016

Researchers report new T2D risk loci in Jordan subpopulations

Nov. 7, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...